Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: In this study we estimated the prevalence, incidence, and mortality of myasthenia gravis (MG) in northern Portugal and characterized the clinical features of the patients identified. METHODS: We used 2 data sources: clinical records from the hospitals and pyridostigmine prescription registers. RESULTS: On December 31, 2013, we estimated a point prevalence of 111.7 patients per million population. The highest prevalence was observed in the group >65 years of age, especially in men (288.1 per million). During 2013, we estimated an incidence rate of 6.3 per million per year. Among women, the incidence rate was highest in the 15-49-year age group; in men, incidence increased with age up to 22.1 per million in those >65 years old. The MG-related mortality rate was 0.5 per million. CONCLUSIONS: These figures are in keeping with similar studies and emphasize the importance of diagnosis and management of MG in elderly populations. Muscle Nerve 54: 413-421, 2016.

Original publication

DOI

10.1002/mus.25068

Type

Journal article

Journal

Muscle Nerve

Publication Date

09/2016

Volume

54

Pages

413 - 421

Keywords

Portugal, clinical, epidemiology, incidence, laboratory, myasthenia gravis, prevalence, Adolescent, Adult, Age Distribution, Aged, Antibodies, Child, Child, Preschool, Databases, Factual, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myasthenia Gravis, Neurologic Examination, Portugal, Prevalence, Receptor Protein-Tyrosine Kinases, Receptors, Cholinergic, Retrospective Studies, Young Adult